Unitaid

From Wikipedia, the free encyclopedia
  (Redirected from UNITAID)
Jump to: navigation, search
UNITAID
Unitaid-logo.png
Founder(s) France, Brazil, Chile, Norway and the United Kingdom
Founded 2006
Location Geneva, Switzerland
Key people Philippe Douste-Blazy, French Foreign Minister and President of UNITAID
Dr.Denis Broun, Executive Director
Area served Global
Focus Health: HIV/AIDS, Malaria, Tuberculosis, Market impact, Drug.
Method Purchase of drugs through negotiations with pharmaceutical companies
Revenue $1,3 billion up-to-date, mostly through a solidarity levy on airline tickets
Website www.unitaid.eu

UNITAID is an international facility for the purchase of drugs against HIV/AIDS, Malaria and Tuberculosis. It was founded in September 2006 on the initiative of Brazil and France, and is to a great part financed by so called innovative development financing mechanisms, namely a solidarity levy on air line tickets.

Hosted by the WHO in Geneva, the organization's principal strength is the negotiation of low prices for drugs on the basis of its strong financial means. UNITAID does not have its own programs for the distribution of medication but supports programs by its partner organizations such as The Global Fund, the Clinton Foundation Health Access Initiative, or the WHO.

Due to a growing number of Member States (29 as of 2008) UNITAID's budget has exceeded US$ 1.3 billion[1] out of which at least 85% must be distributed to low-income countries.

Contents

[edit] History

The political actions towards the establishment of UNITAID had been preceded by two major reports on innovative financing: The Report of the Technical Group on Innovative Financing Mechanisms was formulated upon request by the Heads of State of Brazil, Chile, France and Spain and was published in September 2004; the Landau-report originated in a request by French President Jacques Chirac and was issued in December 2004. Both documents present various opportunities for innovative financing mechanisms while equally stressing the advantages (stability and predictability) of tax-based models.

After these documents had been published, the countries involved in the process tried to turn the international community's attention on innovative development financing. For instance, in February 2005 a joint statement was published by Brazil, Chile, France, Germany, and Spain offering ideas for the financing of the Millennium Development Goals (MDGs);[2] in September of the same year a declaration was announced at a UN-meeting on the MDGs in New York, asking for further examination of innovative sources of financing;[3] this again was followed by an international conference on “Solidarity and Globalization: innovative financing for development and against pandemics”, held between February 28 and March 1, 2006 in Paris.

In the follow-up of this conference, a pilot group on innovative financing of 44 countries was established, and France decided to introduce a solidarity tax on airline tickets, which entered into force on 1 July 2006. Finally, on 17 September 2006, UNITAID was founded by Brazil, Chile, France, Norway and the United Kingdom - while not all of them use air ticket taxation to fulfill their commitment to UNITAID.[4]

Since then, more countries have joined the initiative, among them notably 18 African countries that contribute to UNITAID's funds since February 2007.[5]

On 28 September 2009 UNITAID launched a global ‘Thank you’ campaign to highlight achievements in global health thanks to the steady support of its contributors.[6]

In March 2010 the MassiveGood initiative was unveiled; it collects funds for UNITAID by giving travelers the option to make a small donation each time they book a flight online. The US, UK, Germany, Austria, Switzerland, and Spain participate in MassiveGood.[7]

[edit] Activities and achievements

UNITAID's primary goal is to ensure access to drugs against the most deadly global diseases - HIV/AIDS, Malaria and Tuberculosis.[8] In this context, UNITAID's secondary goals are:

  • to negotiate low prices for already existing forms of medication and to purchase them in high quantities; and
  • to incite the development and mass production of special drugs that do not yet exist or are not yet affordable, such as specifically dosed (paediatric) treatment for HIV/AIDS-infected children or medication for people that have become resistant to standard treatment (so called "Second-line" drugs).[1]

In 2008, UNITAID began to investigate the creation of a "patent pool" to hold patents of AIDS drugs so that they could be manufactured cheaply for use in developing countries.[9] The creation of such a pool was authorized by UNITAID's board in December 2009,[10] and the pool will open for business in October 2010 as a Swiss foundation.

UNITAID is not administering the distribution of drugs itself but seeks partnerships with other organizations. It will then only provide the resources for the purchase of the drugs in question. As a consequence, its activities are mainly focused on the identification of current needs by potential recipients, on the negotiation of long-term contracts with pharmaceutical companies both in the developed and the developing world, and the maintenance of relations to major actors in the field, such as UNICEF, WHO, the Clinton Foundation Health Access Initiative (greater than US$25 million[11]), The Global Fund against HIV/AIDS, Tuberculosis and Malaria, the Stop TB Partnership, and the Global Drug Facility/Green Light Committee.[1]

Despite its relatively short history, UNITAID has already set in motion various projects and has funded existing programs. Some examples are[12]:

  • Anti-retroviral treatment (achieved price reduction: 40%) for 100,000 AIDS-infected children in 34 Asian and African countries by the end of 2007 (partner: Clinton Foundation)
  • Funding of the treatment for 150,000 children suffering from Tuberculosis from September 2007 on (partners: Stop TB Partnership and the Global Drug Facility)
  • Funding of artemisinin-based combination therapies against Malaria in 19 countries (partners: UNICEF and The Global Fund)
  • UNITAID provides money for a WHO program for the prequalification of drugs and will help UNICEF supply pregnant women with HIV test kits and special anti-retroviral treatment

UNITAID also funds the EXPAND-TB project, which aims to expand and excelerate access to diagnostic tests for patients with multi-drug-resistant tuberculosis (MDR-TB). Partners include World Health Organization (WHO), Foundation for Innovative New Diagnostics, Stop TB Partnership Global Laboratory Initiative (GLI) and Global Drug Facility (GDF).[13]

[edit] Criticisms

Unitaid's patent pool has been criticised on the grounds that it is duplicative of many other public and private HIV R&D initiatives. Despite causing less than four per cent of mortality in less developed countries, HIV/AIDS already consumes around 40 per cent of all global health funding for R&D, suggesting that Unitaid's focus on HIV is a mispriotisation of scarce resources.

[edit] Structure

Due to its restricted scope of action, UNITAID has a concise inner structure:

  • The President is UNITAID's official representative. On 3 March 2007, French Foreign Minister Philippe Douste-Blazy was elected president of UNITAID for a two-year term.
  • The Secretariat is located at Geneva, in the WHO-facilities, and is responsible for the day-to-day work of the organization. On 4 May 2007, Dr. Jorge Antonio Zepeda Bermudez (Brazil) took office as the UNITAID Executive Secretary.
  • The Board is the decision-making body of UNITAID. It decides on how the money is spent and which partnerships are being concluded; it also sets the main objectives for the future and decides on action plans. The board has ten members, including five representatives from the founding countries (Brazil, Chile, France, Norway and the United Kingdom), one from Africa chosen by the African Union, one from Asia (South Korea), two from the civil society (NGOs and communities of people living with the diseases) and one from the WHO.[14]

[edit] Members[15]

Contributions through air line ticket taxes come from Chile, Côte d'Ivoire, Democratic Republic of Congo, France, Madagascar, Mauritius, Niger and the Republic of Korea. Norway allocates part of its tax on carbon dioxide emissions from air travel to UNITAID. Regular budget contributions come from Brazil, Cyprus, Luxembourg, Spain, the United Kingdom and the Bill & Melinda Gates Foundation. The other member countries have pledged to support Unitaid in the future.

[edit] See also

[edit] References

  1. ^ a b c http://www.unitaid.eu/EN-Valeur-ajoutee-Unitaid-FIAM.html
  2. ^ http://www.diplomatie.gouv.fr/en/IMG/pdf/Declaration_adoptee_le_11_fevrier_2005_a_Brasilia_par_les_membres_du_groupe_quadripartite_Bresil_Chili_Espagne_Allemagne_France.pdf
  3. ^ http://www.elysee.fr/elysee/elysee.fr/anglais/speeches_and_documents/2005/declaration_on_innovative_sources_of_financing_for_development-60th_anniversary_of_the_united_nations_new_york.31190.html
  4. ^ Innovative ways to fund development - UNITAID, united to treat those in need - Ministère des Affaires étrangères
  5. ^ http://www.unitaid.eu/Nouvelle-traduction-Discours-de-M.html
  6. ^ http://www.unitaid.eu/en/UNITAID-KICKS-OFF-CAMPAIGN-TO-THANK-CONTRIBUTORS-AND-GET-MORE-COUNTRIES-INVOLVED.html
  7. ^ Donald G. Mcneil Jr (2010-03-08). "Counting on Clicks to Finance the Battle Against AIDS, Malaria and Tuberculosis". The New York Times. http://www.nytimes.com/2010/03/09/health/09glob.html?partner=rss&emc=rss. Retrieved 2010-03-09. 
  8. ^ http://www.unitaid.eu/sommaire.php3?lang=en
  9. ^ Donald G. Mcneil Jr (2008-07-08). "Effort for Lower Drug Prices Would Focus on Gaining Patents". The New York Times. http://www.nytimes.com/2008/07/08/health/research/08glob.html?_r=1&scp=4&sq=unitaid&st=nyt. Retrieved 2010-03-09. 
  10. ^ Executive Board (14–15 December 2009), "Resolution no. 5: Patent Pool Implementation Plan", UNITAID, http://www.unitaid.eu/images/EB11/05%20_eb11%20res.5%20implementation%20of%20patent%20pool.pdf 
  11. ^ Contributor Information to the William J. Clinton Foundation
  12. ^ All data is retrieved from UNITAID's homepage at: http://www.unitaid.eu/EN-Valeur-ajoutee-Unitaid-FIAM.html
  13. ^ http://www.unitaid.eu/en/mdr-tb-diagnostics.html
  14. ^ http://www.unitaid.eu/A-simple-and-transparent-operating.html
  15. ^ http://www.unitaid.eu/en/UNITAID-donors.html

[edit] External links

Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages